ARTICLE | Management Tracks
Plus: Ramanayake joins CureVac and updates from Oruka, Madrigal and AusBiotech
By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst
April 25, 2024 12:53 AM UTC


Actym Therapeutics Inc. named Thomas Smart as CEO. Smart was CEO and chair at Gravitas Therapeutics Inc., a company he founded. Actym is delivering immunomodulatory payload combinations to solid tumors using a modified bacterial vector.
CureVac N.V. (NASDAQ:CVAC) hired Thaminda Ramanayake as CBO. Ramanayake joins CureVac from Affini-T Therapeutics Inc., where he also held the CBO role. Before that he was VP, global head of business development in oncology at Sanofi (Euronext:SAN; NASDAQ:SNY)…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/652223/smart-to-lead-actym-as-ceo